Mesenchymal stem cells as anti-inflammatories: Implications for treatment of Duchenne muscular dystrophy

This publication has 142 references indexed in Scilit:

• Allogeneic Mesenchymal Stem Cells for Treatment of Experimental Autoimmune Encephalomyelitis
  Molecular Therapy, 2009
• Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung
  Proceedings of the National Academy of Sciences, 2009
• Muscular Dystrophy Therapy by Nonautologous Mesenchymal Stem Cells: Muscle Regeneration Without Immunosuppression and Inflammation
  Transplantation, 2009
• Trophic macrophages in development and disease
  Nature Reviews Immunology, 2009
• Mesenchymal Stem Cell Transplantation Reverses Multiorgan Dysfunction in Systemic Lupus Erythematosus Mice and Humans
  The International Journal of Cell Cloning, 2009
• Human bone marrow‐derived mesenchymal stem cells induce Th2‐polarized immune response and promote endogenous repair in animal models of multiple sclerosis
  Glia, 2009
• Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production
  Nature Medicine, 2008
• Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy
  Human Molecular Genetics, 2008
• Interferon-γ does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells
  Clinical and Experimental Immunology, 2007
• Menstrual Blood-derived Cells Confer Human Dystrophin Expression in the Murine Model of Duchenne Muscular Dystrophy via Cell Fusion and Myogenic Transdifferentiation
  Molecular Biology of the Cell, 2007